DaShenLin Pharmaceutical Group Co., Ltd. (603233) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

DaShenLin Pharmaceutical Group Co., Ltd.

Why is DaShenLin Pharmaceutical Group Co., Ltd. ?

With ROE of 15.58%, it has a very attractive valuation with a 2.65 Price to Book Value

Over the past year, while the stock has generated a return of 14.65%, its profits have risen by 16.8% ; the PEG ratio of the company is 1
At the current price, the company has a high dividend yield of 3.6

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to DaShenLin Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is DaShenLin Pharmaceutical Group Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

DaShenLin Pharmaceutical Group Co., Ltd.

14.65%

-0.26

29.65%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.77%

EBIT Growth (5y)

6.86%

EBIT to Interest (avg)

9.90

Debt to EBITDA (avg)

0.81

Net Debt to Equity (avg)

0.49

Sales to Capital Employed (avg)

1.64

Tax Ratio

27.74%

Dividend Payout Ratio

77.00%

Pledged Shares

Institutional Holding

ROCE (avg)

17.12%

ROE (avg)

16.57%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.65

EV to EBIT

13.94

EV to EBITDA

6.47

EV to Capital Employed

2.13

EV to Sales

0.86

PEG Ratio

1.01

Dividend Yield

3.63%

ROCE (Latest)

15.29%

ROE (Latest)

15.58%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.07% (YoY

CASH AND EQV(HY)

Highest at CNY 12,976.07 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 4.25%

NET SALES(Q)

Highest at CNY 6,930.91 MM

PRE-TAX PROFIT(Q)

Highest at CNY 645.74 MM

NET PROFIT(Q)

Highest at CNY 457.18 MM

EPS(Q)

Highest at CNY 0.41

-10What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 3,647.88 MM

INTEREST(HY)

At CNY 126.19 MM has Grown at 5.36%

OPERATING PROFIT(Q)

Lowest at CNY 665.23 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.6 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 15.72%

Here's what is working for DaShenLin Pharmaceutical Group Co., Ltd.

Net Sales

Highest at CNY 6,930.91 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 645.74 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 457.18 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.41

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 12,976.07 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 4.25%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -4.07% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for DaShenLin Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 3,647.88 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 665.23 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 9.6 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Interest

At CNY 126.19 MM has Grown at 5.36%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 15.72%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio